MIM
Monashee Investment Management’s AN2 Therapeutics ANTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-33,997
| Closed | -$697K | – | 106 |
|
|
2023
Q4 | $697K | Sell |
33,997
-65,498
| -66% | -$1.34M | 0.12% | 37 |
|
|
2023
Q3 | $1.6M | Sell |
99,495
-82,500
| -45% | -$1.33M | 0.67% | 47 |
|
|
2023
Q2 | $1.55M | Sell |
181,995
-65,472
| -26% | -$557K | 0.37% | 42 |
|
|
2023
Q1 | $2.44M | Sell |
247,467
-202,533
| -45% | -$2M | 0.67% | 32 |
|
|
2022
Q4 | $4.29M | Buy |
450,000
+216,670
| +93% | +$2.06M | 1.85% | 17 |
|
|
2022
Q3 | $4.06M | Hold |
233,330
| – | – | 1.5% | 7 |
|
|
2022
Q2 | $1.81M | Sell |
233,330
-200,000
| -46% | -$1.55M | 0.66% | 13 |
|
|
2022
Q1 | $6.53M | Buy |
+433,330
| New | +$6.53M | 1.89% | 2 |
|